NXLNexalin Technology, Inc.

Nasdaq nexalin.com


$ 1.73 $ -1.23 (-41.55 %)    

Friday, 28-Jun-2024 15:59:41 EDT
QQQ $ 479.98 $ -3.41 (-0.71 %)
DIA $ 391.11 $ -0.45 (-0.11 %)
SPY $ 544.70 $ -1.67 (-0.31 %)
TLT $ 91.77 $ -1.75 (-1.87 %)
GLD $ 215.03 $ 0.04 (0.02 %)
$ 1.69
$ 1.93
$ 0.00 x 0
$ 0.00 x 0
$ 1.67 - $ 2.18
$ 0.25 - $ 4.05
8,073,477
na
22.01M
$ 1.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-27-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-nexalin-technology-raises-525m-via-public-offering-of-3m-shares-at-175share

Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW))))Ā (the "Company" or "Nexalin") today announced the pricing of a p...

 updated-nexalin-technology-files-prospectus-for-the-offering-of-up-to-7m-of-common-stock-at-an-assumed-price-of-226-per-share

- SEC Filing We are offering on a reasonable best effort basis up to $7,000,000 of our common stock, $0.001 par value per shar...

 nexalin-technology-announces-clinical-study-data-in-major-depressive-disorder-and-publication-of-clinical-trial-results-in-leading-scientific-journal-brain-stimulation

Study demonstrates strong statistical separation between patients receiving Nexalin's DIFSĀ® technology in combination with ...

 watching-nexalin-technology-shares-see-volume-amid-traders-circulation-of-redchip-companies-youtube-page-with-video-saying-nexalin-technologys-solution-to-the-multi-billion-sleep-problem

https://www.youtube.com/watch?v=6nIaEXjW_uI

 nexalin-technology-files-prospectus-for-the-sale-of-up-to-7m-of-common-stock-in-public-offering

- SEC Filing

 why-are-nexalin-technology-shares-surging-friday

Nexalin Technology, Inc. (NASDAQ: NXL) shares surged on Friday afternoon following the announcement of a new patent awarded by ...

 nano-cap-nexalin-technology-secures-us-patent-for-stimulation-device-for-alzheimers-and-dementia-treatment

Nexalin Technology has received U.S. patent for its non-invasive Deep Intracranial Frequency Stimulation device for Alzheimer&#...

 nexalin-technology-awarded-us-patent-12011591	transcranial-alternating-current-dynamic-frequency-stimulation-tacs-method-for-alzheimers-and-dementia

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12011591